Fully Integrated Drug Testing Services
WuXi AppTec’s Laboratory Testing Division is a comprehensive and integrated testing platform for drug and medical device development. We support customers across the full spectrum of their development efforts to deliver innovative treatments to patients.
WuXi AppTec’s preclinical testing platform combines world-class drug development services with cross-functional program management and global regulatory expertise to support Investigational New Drug (IND) applications. With capabilities in safety assessment, absorption, distribution, metabolism and excretion (ADME), Drug Metabolism and Pharmacokinetics (DMPK), bioanalytical, pharmacology, Chemistry, Manufacturing and Controls (CMC) and analytical services all under one roof, WuXi AppTec can support the full scope of your drug development programs, from IND-enabling studies to document preparation and submission.
- General Toxicology
- Safety Pharmacology
- Genetic & in vitro Toxicology
- Developmental & Reproductive Toxicology
- Carcinogenicity Testing
- Ophthalmology Services
- Preclinical Development of Biologics
- Preclinical Immunology Services
- Vaccine Development
- Standard for Exchange of Nonclinical Data (SEND)
To ensure exceptional quality across our laboratories, the DMPK team operates in accordance with global regulatory guidelines, and is fully accredited by AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care).